Reports
Reports
The global smart inhalers market attained a value of USD 87.61 million in 2022. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 56% to reach USD 1262.8 million by 2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Smart inhalers are referred to as the devices that enable the delivery of a variety of medication via inhalation. They are termed as smart due to sensors that are attached to the inhalers monitoring the correct dose per intake as well as the technique used while inhaling the medication.
The smart inhalers market is segmented based on products, indications, and distribution channels.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of products, the smart inhalers market is divided into:
Based on indication, the smart inhalers market is segmented into:
On the basis of distribution channels, the smart inhalers market is divided into:
The EMR report looks into the regional smart inhalers markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global smart inhalers market is driven by the smart and effective manner to inhale the medicine, as compared to the usual inhalers. Recent developments in the manufacturing of smart inhalers, as well as devices having built-in smart inhalers, are expected to aid the smart inhalers market growth. The rise in the prevalence of people who have asthma and chronic obstructive pulmonary diseases is expected to enhance the market growth.
The report presents a detailed analysis of the following key players in the global smart inhalers market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Indication, Distributional channels, Region |
Breakup by Product | Inhalers, Nebulizers |
Breakup by Indication | Asthma, COPD |
Breakup by Distributional channels | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Adherium Limited, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cohero Health, Inc., Teva Pharmaceutical Industries Limited, GlaxoSmithKline plc, Vectura Group plc, Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Smart Inhalers Market Analysis
8.1 Key Industry Highlights
8.2 Global Smart Inhalers Historical Market (2018-2022)
8.3 Global Smart Inhalers Market Forecast (2023-2028)
8.4 Global Smart Inhalers Market by Product
8.4.1 Inhalers
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.1.4 Inhalers by Type
8.4.1.4.1 Dry Powder Inhalers
8.4.1.4.2 Metered Dose Inhalers
8.4.2 Nebulizers
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Smart Inhalers Market by Indication
8.5.1 Asthma
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 COPD
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.6 Global Smart Inhalers Market by Distributional Channels
8.6.1 Hospital Pharmacies
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Retail Pharmacies
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Online Pharmacies
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.7 Global Smart Inhalers Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Adherium Limited
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 AstraZeneca PLC
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Boehringer Ingelheim International GmbH
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Cohero Health, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Teva Pharmaceutical Industries Limited
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 GlaxoSmithKline plc
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Vectura Group plc
12.2.7.1 Company Overview
12.2.7.2 Product Portfolio
12.2.7.3 Demographic Reach and Achievements
12.2.7.4 Certifications
12.2.8 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Smart Inhalers Market: Key Industry Highlights, 2018 and 2028
2. Global Smart Inhalers Historical Market: Breakup by Product (USD Million), 2018-2022
3. Global Smart Inhalers Market Forecast: Breakup by Product (USD Million), 2023-2028
4. Global Smart Inhalers Historical Market: Breakup by Indication (USD Million), 2018-2022
5. Global Smart Inhalers Market Forecast: Breakup by Indication (USD Million), 2023-2028
6. Global Smart Inhalers Historical Market: Breakup by Distributional Channels (USD Million), 2018-2022
7. Global Smart Inhalers Market Forecast: Breakup by Distributional Channels (USD Million), 2023-2028
8. Global Smart Inhalers Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Smart Inhalers Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Smart Inhalers Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Smart Inhalers Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Smart Inhalers Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Smart Inhalers Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Smart Inhalers Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Smart Inhalers Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Smart Inhalers Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Smart Inhalers Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Smart Inhalers Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Smart Inhalers Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Smart Inhalers Market Structure
In 2022, the global smart inhalers market attained a value of nearly USD 87.61 million.
The market is projected to grow at a CAGR of 56% between 2023 and 2028.
The industry is driven by the growing geriatric population worldwide, increasing preference towards smart and effective inhalers, the growing investments in the medical sector, and the growing innovations in the manufacturing of smart inhalers.
The key trend propelling the industry growth include the growing incidences of asthma and chronic obstructive pulmonary disease (COPD) worldwide.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The significant products include inhalers and nebulisers.
The major segments based on indication include asthma and COPD.
The significant distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.
The major players in the industry are Adherium Limited, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cohero Health, Inc., Teva Pharmaceutical Industries Limited, GlaxoSmithKline plc, Vectura Group plc, and others.
The global smart inhalers market attained a value of USD 87.61 million in 2022, driven by the growing incidences of asthma and chronic obstructive pulmonary diseases (COPD). Aided by the rapid technological advancements in the manufacturing of smart inhalers, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 56%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product, the global smart inhalers industry can be segmented into inhalers and nebulisers. On the basis of indication, the major segments are asthma and COPD. On the basis of distribution channels, the industry can be segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The major regional markets for smart inhalers are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific. The key players in the above market include Adherium Limited, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cohero Health, Inc., Teva Pharmaceutical Industries Limited, GlaxoSmithKline plc, Vectura Group plc, and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.